Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 22(1)2017 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-28106809

RESUMEN

A new phenylpropanoid glycoside (1), and two new coumarin glycosides (2, 3), together with two known compounds (4, 5), have been isolated from the stems of Hydrangea paniculata Sieb. Their structures have been determined by spectroscopic and chemical methods. Furthermore, compound 1 (50 µM) exhibited significant hepatoprotective activity against N-acetyl-p-aminophenol (APAP)-induced HepG2 cell damage in vitro assays.


Asunto(s)
Cumarinas/química , Glicósidos/química , Hydrangea/química , Propanoles/química , Sustancias Protectoras/química , Acetaminofén/antagonistas & inhibidores , Acetaminofén/toxicidad , Antipiréticos/antagonistas & inhibidores , Antipiréticos/toxicidad , Cumarinas/aislamiento & purificación , Cumarinas/farmacología , Glicósidos/aislamiento & purificación , Glicósidos/farmacología , Células Hep G2 , Humanos , Estructura Molecular , Tallos de la Planta/química , Propanoles/aislamiento & purificación , Propanoles/farmacología , Sustancias Protectoras/aislamiento & purificación , Sustancias Protectoras/farmacología , Relación Estructura-Actividad
2.
J Pharm Sci ; 104(1): 257-65, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25417766

RESUMEN

Paracetamol has an extensive first-pass metabolism that highly affects its bioavailability (BA); thus, dose may be repeated several times a day in order to have longer efficacy. However, hepatotoxicity may arise because of paracetamol metabolism. Therefore, this project aimed to increase paracetamol BA in rats by glucosamine (GlcN). At GlcN-paracetamol racemic mixture ratio of 4:1 and paracetamol dose of 10 mg/kg, paracetamol area under the curve (AUC) and maximum concentration (Cmax ) were significantly increased by 99% and 66%, respectively (p < 0.05). Furthermore, paracetamol AUC and Cmax levels were increased by 165% and 88% in rats prefed with GlcN for 2 days (p < 0.001). Moreover, GlcN significantly reduced phase Ι and phase I/ΙΙ metabolic reactions in liver homogenate by 48% and 54%, respectively. Furthermore, GlcN molecule was found to possess a good in silico binding mode into the CYP2E1 active site-forming bidentate hydrogen bonding with the Thr303 side chain. Finally, serum ALT and AST levels of rats-administered high doses of paracetamol were significantly reduced when rats were prefed with GlcN (p < 0.01). In conclusion, GlcN can increase the relative BA of paracetamol through reducing its metabolism. This phenomenon is associated with reduction in hepatocytes injury following ingestion of high doses of paracetamol.


Asunto(s)
Acetaminofén/farmacocinética , Analgésicos no Narcóticos/farmacocinética , Inhibidores del Citocromo P-450 CYP2E1/uso terapéutico , Suplementos Dietéticos , Interacciones Alimento-Droga , Glucosamina/uso terapéutico , Hígado/metabolismo , Acetaminofén/antagonistas & inhibidores , Acetaminofén/sangre , Acetaminofén/envenenamiento , Analgésicos no Narcóticos/sangre , Analgésicos no Narcóticos/química , Analgésicos no Narcóticos/envenenamiento , Animales , Antipiréticos/antagonistas & inhibidores , Antipiréticos/sangre , Antipiréticos/farmacocinética , Antipiréticos/envenenamiento , Disponibilidad Biológica , Biotransformación , Conformación de Carbohidratos , Dominio Catalítico , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Citocromo P-450 CYP2E1/química , Citocromo P-450 CYP2E1/metabolismo , Inhibidores del Citocromo P-450 CYP2E1/química , Inhibidores del Citocromo P-450 CYP2E1/metabolismo , Bases de Datos de Proteínas , Femenino , Glucosamina/química , Glucosamina/metabolismo , Humanos , Ligandos , Hígado/efectos de los fármacos , Hígado/enzimología , Simulación del Acoplamiento Molecular , Conformación Proteica , Ratas Sprague-Dawley
3.
Chem Biol Interact ; 223: 80-6, 2014 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-25265579

RESUMEN

Overdose of acetaminophen (APAP) can cause acute liver injury that is sometimes fatal, requiring efficient pharmacological intervention. The traditional Chinese herb Bupleurum falcatum has been widely used for the treatment of several liver diseases in eastern Asian countries, and saikosaponin d (SSd) is one of its major pharmacologically-active components. However, the efficacy of Bupleurum falcatum or SSd on APAP toxicity remains unclear. C57/BL6 mice were administered SSd intraperitoneally once daily for 5days, followed by APAP challenge. Biochemical and pathological analysis revealed that mice treated with SSd were protected against APAP-induced hepatotoxicity. SSd markedly suppressed phosphorylation of nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) and reversed the APAP-induced increases in the target genes of NF-κB, such as pro-inflammatory cytokine Il6 and Ccl2, and those of STAT3, such as Socs3, Fga, Fgb and Fgg. SSd also enhanced the expression of the anti-inflammatory cytokine Il10 mRNA. Collectively, these results demonstrate that SSd protects mice from APAP-induced hepatotoxicity mainly through down-regulating NF-κB- and STAT3-mediated inflammatory signaling. This study unveils one of the possible mechanisms of hepatoprotection caused by Bupleurum falcatum and/or SSd.


Asunto(s)
Acetaminofén/antagonistas & inhibidores , Acetaminofén/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Ácido Oleanólico/análogos & derivados , Saponinas/farmacología , Analgésicos no Narcóticos/toxicidad , Animales , Antipiréticos/antagonistas & inhibidores , Antipiréticos/toxicidad , Bupleurum , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Citocinas/genética , Regulación hacia Abajo/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Humanos , Inactivación Metabólica/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , FN-kappa B/metabolismo , Ácido Oleanólico/farmacología , Estrés Oxidativo/efectos de los fármacos , PPAR alfa/metabolismo , Plantas Medicinales , ARN Mensajero/genética , ARN Mensajero/metabolismo , Factor de Transcripción STAT3/metabolismo , Transducción de Señal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA